The next CRCtalks event is TOMORROW, April 11th at 1:00 PM ET. Register today, it's free! The topic is Liver Directed Therapy for mCRC Patients. We will be talking with gastrointestinal oncologist Louise Connell, MB BCh BAO, BMedSc, of Memorial Sloan Kettering in a discussion…

Truly amazed by Anna D. Barker, Ph.D & all she has done in her career, especially for patient advocates. The Scientist->Survivor program is like no other. The training, education & connections we make are life changing! Thank you Dr. Barker, AACR AACR_CEO Carrie Treadwell #AACR24 #AACRSSP

Dr. Kobayashi presents a trial on peritoneal lavage cytology in patients with stage II and III colorectal cancer. Interesting that pts with positive cytology only had 10-12% peritoneal recurrence. #GI24

Happening now Qian Shi, PhD presenting on clinical trials & beyond the P Value at ASCO #GI24 The figure below discussing phases is one I plan to share with any patient who asks questions about trials to help better understand them. #crcsm #clinicaltrials

'Remember when mKRAS was considered undruggable?' - slide title Dr. Azad at #GI24 .

Yes, and more progress to be made in more prevalent RAS isoforms, with better preclinical evidence for selection of companion agents (i.e. let's add IO with purpose rather than 'me too' strategies

Starting off this morning at ASCO #GI24 listening to Bishal Gyawali as he discusses clinical trial design. Does PFS correlate with QOL? #clinicaltrials

Cancer Incidence Rising Among Adults Younger Than 50. John Marshall discusses new research by American Cancer Society on how Colorectal Cancer is driving this alarming trend. CNN Brian Todd Watch now: ms.spr.ly/6012iSLTE. MedStar Georgetown Georgetown Lombardi

Great presentation on artificial intelligence approaches to palliative and supportive care by Ravi B. Parikh at ASCO #GI24 The quote that stuck out to me during this talk was 'predicting right versus easy' and as a cancer patient/survivor I appreciate this SO MUCH!

Don’t fumble your health: prevent colon cancer by getting checked today.

Visit LeadFromBehind.org to learn more.

#LeadFromBehind

Day 1 at #ASCOQLTY23 . Stop by the poster F15 and learn more from Kim Newcomer about our community driven support platform #BlueHq : an innovative solution to address the needs of patients with #CRC ASCO

ASCO Dr. Kelly Shanahan Erin Kent Bridgette Thom, PhD Utibe R. Essien, MD MPH Arjun Gupta Qasim Hussaini, MD Duke Cancer Dr Bridgette Thom, PhD on 'System-Level Changes to Decrease the Financial Hardship of Modern Cancer Care for Patients and Families'
1⃣Patient education, literacy, assistance
2⃣Care Team Practice Change i.e telehealth
3⃣Health system investment i.e screening & process change
#ASCOQLTY23

The amazing Dr. Kelly Shanahan is speaking about the lived experience of the high-cost of cancer care at #ASCOQLTY23 . #Patientsaredrowning ASCO

ASCO Dr. Kelly Shanahan Erin Kent Bridgette Thom, PhD Utibe R. Essien, MD MPH Arjun Gupta Qasim Hussaini, MD Duke Cancer Dr Utibe R. Essien, MD MPH on 'Affordability Barriers to Equitable Delivery of Novel Cancer Treatments'
1⃣There is a known racial wealth gap
2⃣There are known racial dispartities
3⃣There are cost related disparities
4⃣Costs WIDEN the gap in equitable care

#Pharmacoequity 💊 #ASCOQLTY23

Dr Utibe R. Essien, MD MPH describes the critical framework to support #Pharmacoequity :

Negotiate 3rd Party Prices: 💵💰
Reduced drug cost: 💉💊
Stopping long term patents: 📉📜
Changing policy/politics: 🏛️🧑‍⚖️

#ASCOQLTY23

Day 1 at #ASCOQLTY23 Dr Utibe R. Essien, MD MPH discussing the affordability barriers to equitable cancer care related to #disparities Colorectal Cancer Alliance ASCO

Flag sighting! Having the best time on our Dawn and Zac Travel group trip to Spain and Portugal. Spent the day in the beautiful city of Toledo, Spain 🇪🇸 #grouptours #visitspain #spaintour #dawnandzactravel #traveltheworldwithus

“The outrageous persona of President Camacho demands the attention this cause deserves. Reprising this role felt like the perfect way to continue to raise awareness and encourage people to get screened.”
m.imdb.com/news/ni6417121…

Michael Sapienza, CEO of the Colorectal Cancer Alliance, stressed the importance of preventive checkups, detailing how screenings can 'prevent colon cancer through the detection and removal of precancerous growths called polyps.'
yahoo.com/entertainment/…

The Alliance recently welcomed Jerry J.K. Tillery to the staff as its first Chief Impact Officer. Jerry will oversee the organization’s operations and programmatic departments, with a focus on growth and reaching more allies. bit.ly/CCANewCIO

The amazing Michael Sapienza of Colorectal Cancer Alliance discussing some data from their #colorectalcancer Never Too Young Survey & their new platform BlueHQ that will help support, navigate, and provide so many resources to the cancer community! SE CRC Consortium #crcsm #ayacsm